• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿昔洛韦持续输注的可行性。

Feasibility of Continuous Infusions of Acyclovir.

作者信息

O'Leary Christine K, Jones Cheryl, Bryant Penelope A, Abo Yara-Natalie, Osowicki Joshua, Gwee Amanda

机构信息

From the Department of General Medicine, The Royal Children's Hospital, Victoria, Australia.

Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, NSW, Australia.

出版信息

Pediatr Infect Dis J. 2020 Sep;39(9):830-832. doi: 10.1097/INF.0000000000002692.

DOI:10.1097/INF.0000000000002692
PMID:32796409
Abstract

Current guidelines for severe herpes simplex virus infection recommend 21 days of intravenous therapy. The thrice-daily administration of intravenous acyclovir makes it challenging to deliver as outpatient therapy. We describe 2 cases with confirmed or presumed neonatal herpes simplex virus encephalitis treated with acyclovir administered as a continuous-infusion at home and review the pharmacologic and clinical evidence for continuous infusions of acyclovir.

摘要

目前针对严重单纯疱疹病毒感染的指南推荐进行21天的静脉治疗。静脉注射阿昔洛韦每日三次给药,使得作为门诊治疗实施起来具有挑战性。我们描述了2例确诊或疑似新生儿单纯疱疹病毒性脑炎的病例,这些病例在家中接受了阿昔洛韦持续静脉输注治疗,并回顾了阿昔洛韦持续静脉输注的药理学和临床证据。

相似文献

1
Feasibility of Continuous Infusions of Acyclovir.阿昔洛韦持续输注的可行性。
Pediatr Infect Dis J. 2020 Sep;39(9):830-832. doi: 10.1097/INF.0000000000002692.
2
High-dose acyclovir combined with foscavir (foscarnet) in the management of severe herpes simplex virus meningoencephalitis.大剂量阿昔洛韦联合膦甲酸钠治疗重症单纯疱疹病毒性脑膜脑炎
Rev Neurol (Paris). 2017 Apr;173(4):240-242. doi: 10.1016/j.neurol.2017.03.006. Epub 2017 Mar 28.
3
Delayed Recurrence of Herpes Simplex Virus Infection in the Central Nervous System After Neonatal Infection and Completion of Six Months of Suppressive Therapy.新生儿感染后中枢神经系统单纯疱疹病毒感染复发延迟和完成六个月抑制治疗。
J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):e177-e179. doi: 10.1093/jpids/pix017.
4
Efficacy of continuous acyclovir infusion in neonatal herpes virus encephalitis.阿昔洛韦持续输注治疗新生儿疱疹病毒性脑炎的疗效
Neuropediatrics. 2009 Aug;40(4):199-200. doi: 10.1055/s-0029-1241187. Epub 2010 Feb 4.
5
Untreated herpes simplex virus encephalitis without a fatal outcome.未经治疗的单纯疱疹病毒脑炎,无致命结局。
J Neurovirol. 2021 Jun;27(3):493-497. doi: 10.1007/s13365-021-00968-y. Epub 2021 Mar 31.
6
Herpes encephalitis.疱疹性脑炎
Med Clin (Barc). 2020 Jan 24;154(2):72. doi: 10.1016/j.medcli.2019.03.030. Epub 2019 May 30.
7
Steroid pulse therapy in herpes simplex encephalitis.单纯疱疹性脑炎的类固醇冲击疗法。
Neurosciences (Riyadh). 2013 Jul;18(3):276-7.
8
Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study.成年患者单纯疱疹病毒性脑炎的结局及预后因素:一项多中心研究结果
Clin Infect Dis. 2002 Aug 1;35(3):254-60. doi: 10.1086/341405. Epub 2002 Jul 10.
9
[Herpes simplex virus type 1 encephalitis].[单纯疱疹病毒1型脑炎]
Med Klin (Munich). 2004 Aug 15;99(8):441-6. doi: 10.1007/s00063-004-1067-9.
10
Herpes simplex encephalitis following microvascular decompression for trigeminal neuralgia.三叉神经痛微血管减压术后单纯疱疹病毒性脑炎。
J Neurosurg. 2013 Mar;118(3):530-3. doi: 10.3171/2012.11.JNS121386. Epub 2013 Jan 4.

引用本文的文献

1
Shedding a Light on Acyclovir Pharmacodynamics: A Retrospective Analysis on Pharmacokinetic/Pharmacodynamic Modelling of Acyclovir for the Treatment of Varicella Zoster Virus Infection in Immunocompromised Patients: A Pilot Study.解读阿昔洛韦的药效学:一项关于阿昔洛韦治疗免疫功能低下患者水痘带状疱疹病毒感染的药代动力学/药效学建模的回顾性分析:一项初步研究。
Pharmaceutics. 2022 Oct 27;14(11):2311. doi: 10.3390/pharmaceutics14112311.
2
Herpesvirus-Associated Encephalitis: an Update.疱疹病毒相关性脑炎:最新进展
Curr Trop Med Rep. 2022;9(3):92-100. doi: 10.1007/s40475-022-00255-8. Epub 2022 Sep 23.
3
Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients.
静脉注射阿昔洛韦在儿科肿瘤患者中的群体药代动力学
Front Pharmacol. 2022 Apr 14;13:865871. doi: 10.3389/fphar.2022.865871. eCollection 2022.